Publications (74) Publications auxquelles un chercheur a participé

2017

  1. 11C-Methionine-PET in multiple myeloma: A combined study from two different institutions

    Theranostics, Vol. 7, Núm. 11, pp. 2956-2964

  2. A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials

    Leukemia, Vol. 31, Núm. 2, pp. 318-324

  3. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

    Journal of Translational Medicine, Vol. 15, Núm. 1

  4. An in-silico approach to predict and exploit synthetic lethality in cancer metabolism

    Nature Communications, Vol. 8, Núm. 1

  5. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

    Journal of Vascular Surgery: Venous and Lymphatic Disorders

  6. Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma

    Leukemia

  7. Antibody-dependent cell cytotoxicity: Immunotherapy strategies enhancing effector NK cells

    Immunology and Cell Biology, Vol. 95, Núm. 4, pp. 347-355

  8. Antitumor effect of an adeno-associated virus expressing apolipoprotein A-1 fused to interferon alpha in an interferon alpha-resistant murine tumor model

    Oncotarget, Vol. 8, Núm. 3, pp. 5247-5255

  9. Arterial spin labeling MRI is able to detect early hemodynamic changes in diabetic nephropathy

    Journal of Magnetic Resonance Imaging, Vol. 46, Núm. 6, pp. 1810-1817

  10. BCL6 antagonizes NOTCH2 to maintain survival of human follicular lymphoma cells

    Cancer Discovery, Vol. 7, Núm. 5, pp. 506-521

  11. Bioresorbable polymers for next-generation cardiac scaffolds

    Bioresorbable Polymers for Biomedical Applications: From Fundamentals to Translational Medicine (Elsevier), pp. 445-467

  12. Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing

    Current Osteoporosis Reports, Vol. 15, Núm. 5, pp. 499-506

  13. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

    The Lancet, Vol. 390, Núm. 10094, pp. 555-566

  14. CM352 reduces brain damage and improves functional recovery in a rat model of intracerebral hemorrhage

    Journal of the American Heart Association, Vol. 6, Núm. 6

  15. CREBBP inactivation promotes the development of HDAC3-dependent lymphomas

    Cancer Discovery, Vol. 7, Núm. 1, pp. 38-53

  16. Cardiac drug delivery

    Drug Delivery: An Integrated Clinical and Engineering Approach (CRC Press), pp. 439-480

  17. Cellular immunotherapies for cancer

    OncoImmunology, Vol. 6, Núm. 5

  18. Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes

    Cancer Letters, Vol. 409, pp. 42-48

  19. Clinical perspectives on the management of bleeding in patients on oral anticoagulants: The DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsa

    Emergencias, Vol. 29, Núm. 1, pp. 18-26

  20. Combined PI3K/Akt and Smad2 activation promotes corneal endothelial cell proliferation

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 2, pp. 745-754